Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;185(4):736-744.
doi: 10.1111/bjd.20428. Epub 2021 Jul 5.

Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines

W Y Haw  1   2 , A Al-Janabi  1   2 , B W M Arents  3 , L Asfour  1 , L S Exton  4 , D Grindlay  5 , S S Khan  1 , L Manounah  4 , H Yen  6 , C-C Chi  6   7 , E J van Zuuren  8 , C Flohr  9 , Z Z N Yiu  1   2
Affiliations

Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines

W Y Haw et al. Br J Dermatol. 2021 Oct.

Abstract

Background: Clinical practice guidelines (CPGs) play a critical role in standardizing and improving treatment outcomes based on the available evidence. It is unclear how many CPGs are available globally to assist clinicians in the management of patients with skin disease.

Objectives: To search for and identify CPGs for dermatological conditions with the highest burden globally.

Methods: We adapted a list of 12 dermatological conditions with the highest burden from the Global Burden of Disease (GBD) study 2019. A systematic literature search was done to identify CPGs published between October 2014 to October 2019. The scoping review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework.

Results: A total of 226 CPGs were included. Melanoma had the greatest representation in the CPGs, followed by dermatitis and psoriasis. Skin cancers had a relatively high CPG representation but with lower GBD disease burden ranking. There was an uneven distribution by geographical region, with resource-poor settings being under-represented. The skin disease categories of the CPGs correlated weakly with the GBD disability-adjusted life-years metrics. Eighty-nine CPGs did not have funding disclosures and 34 CPGs were behind a paywall.

Conclusions: The global production of dermatology CPGs showed wide variation in geographical representation, article accessibility and reporting of funding. The number of skin disease CPGs were not commensurate with its disease burden. Future work will critically appraise the methodology and quality of dermatology CPGs and lead to the production of an accessible online resource summarizing these findings.

PubMed Disclaimer

Comment in

References

    1. Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Graham R, Mancher M. Clinical practice guidelines we can trust: National Academies Press Washington, DC. 2011: 1: Introduction. Available at: https://www.ncbi.nlm.nih.gov/books/NBK209546/ (last accessed 21 May 2021).
    1. Kredo T, Bernhardsson S, Machingaidze S et al. Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care 2016; 28:122-8.
    1. Yiu Z, Chi CC, Flohr C. All aboard the BJD for global dissemination of high-quality dermatology clinical practice guidelines. Br J Dermatol 2020; 183:3-4.
    1. Moher D, Glasziou P, Chalmers I et al. Increasing value and reducing waste in biomedical research: who’s listening? Lancet 2016; 387:1573-86.
    1. Werner RN, Marinović B, Rosumeck S et al. The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument. J Eur Acad Dermatol Venereol 2016; 30:395-403.

Publication types